A regulatory network comprising let-7 miRNA and SMUG1 is associated with good prognosis in ER+ breast tumours

Author:

Lirussi Lisa12,Ayyildiz Dilara3,Liu Yan2,Montaldo Nicola P1,Carracedo Sergio12,Aure Miriam R4,Jobert Laure1,Tekpli Xavier4,Touma Joel56,Sauer Torill67,Dalla Emiliano3ORCID,Kristensen Vessela N47,Geisler Jürgen68,Piazza Silvano9,Tell Gianluca3ORCID,Nilsen Hilde1210ORCID

Affiliation:

1. Institute of Clinical Medicine, Department of Clinical Molecular Biology, University of Oslo , N-0318 Oslo, Norway

2. Section of Clinical Molecular Biology, Akershus University Hospital (AHUS) , 1478 Lørenskog, Norway

3. Laboratory of Molecular Biology and DNA repair, Department of Medicine, University of Udine , p.le M. Kolbe 4, 33100 Udine, Italy

4. Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital , 0450 Oslo, Norway

5. Department of Breast and Endocrine Surgery, Akershus University Hospital (AHUS) , 1478 Lørenskog, Norway

6. Institute of Clinical Medicine, University of Oslo , Campus AHUS, 1478 Lørenskog, Norway

7. Department of Pathology, Akershus University Hospital , 1478 Lørenskog, Norway

8. Department of Oncology, Akershus University Hospital (AHUS) , 1478 Lørenskog, Norway

9. Bioinformatics Core Facility, Centre for Integrative Biology (CIBIO), University of Trento , via Sommarive 18, 38123, Povo (Trento), Italy

10. Department of Microbiology, Oslo University Hospital , N-0424 Oslo, Norway

Abstract

Abstract Single-strand selective uracil–DNA glycosylase 1 (SMUG1) initiates base excision repair (BER) of uracil and oxidized pyrimidines. SMUG1 status has been associated with cancer risk and therapeutic response in breast carcinomas and other cancer types. However, SMUG1 is a multifunctional protein involved, not only, in BER but also in RNA quality control, and its function in cancer cells is unclear. Here we identify several novel SMUG1 interaction partners that functions in many biological processes relevant for cancer development and treatment response. Based on this, we hypothesized that the dominating function of SMUG1 in cancer might be ascribed to functions other than BER. We define a bad prognosis signature for SMUG1 by mapping out the SMUG1 interaction network and found that high expression of genes in the bad prognosis network correlated with lower survival probability in ER+ breast cancer. Interestingly, we identified hsa-let-7b-5p microRNA as an upstream regulator of the SMUG1 interactome. Expression of SMUG1 and hsa-let-7b-5p were negatively correlated in breast cancer and we found an inhibitory auto-regulatory loop between SMUG1 and hsa-let-7b-5p in the MCF7 breast cancer cells. We conclude that SMUG1 functions in a gene regulatory network that influence the survival and treatment response in several cancers.

Funder

Research Council of Norway

South East Regional Health Authority

Norwegian Cancer Society

AIRC

Publisher

Oxford University Press (OUP)

Subject

Genetics

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3